| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703544 | Null | 0.0414190425892865 | 0.30451144 |
| NSC 707904 | Null | 0.0414190425892865 | 0.21400026 |
| NSC 719715 | Null | 0.0414190425892865 | 0.5191173 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.0414190425892865 | 0.46459902 |
| NSC 720386 | Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane | 0.0414190425892865 | 0.18014467 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0414190425892865 | 0.47987234 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0414190425892865 | 0.40825875 |
| NSC 735408 | Null | 0.0414190425892865 | 0.49089297 |
| NSC 740 | Methotrexate | 0.0414190425892865 | 0.19161289 |
| NSC 763059 | Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride | 0.0414190425892865 | 0.11182778 |